The diabetes drug arena is getting more crowded by the day as new classes of drugs like SGLT-2 inhibitors and GLP-1 analogs seem to be getting approved at a quick pace. In addition there are classes of drugs that are in phase 2 and 3 trials that we have yet …
Read More »Monthly Archives: October 2014
Garmin Vivofit
Garmin Vivofit The Heart Rate Watch Company rated this the best of show for CES 2014. Unlike bands that have to be recharged every few days, it uses a coin battery that should last a year. It tracks inactivity with a red bar that grows as you sit to remind …
Read More »Editor’s Note, GLP-1 Agonist Special Edition, October 2014
I was in a doctor’s office last week and reached into a drawer to get a pen and, lo and behold, I came out with one of those old metal GLP-1 promotional pens. It was silver with orange yellow and blue-green strips, and felt really good in my hand. It …
Read More »Stricter Glycemic Control after Coronary Artery Bypass Surgery Evaluated
Prospective study shows that maintenance of glucose levels in a liberal target range is safer and more beneficial than a tight target range after CABG… Hyperglycemia after coronary artery bypass graft (CABG) has been associated with increased mortality but according to recent studies, regulating glucose levels in a liberal target …
Read More »FDA Accepts Filing of NDA for Empagliflozin/Metformin Fixed-dose Combination
The single pill could help type 2 diabetes patients manage their blood sugar more effectively…. The U.S. Food and Drug Administration (FDA) has accepted the filing of a New Drug Application (NDA) for empagliflozin plus immediate-release metformin hydrochloride fixed-dose combination, an investigational compound being studied for the treatment of adults …
Read More »Low Testosterone Increases Risk of Atherosclerosis for Men with Diabetes
Men with low testosterone have more than a 40% higher relative risk than men with normal testosterone…
Read More »Long-term Effects of Rapid Weight Loss vs. Gradual Weight Loss
No significant correlation found between rate of weight loss and rate of weight regain in obese patients…
Read More »Generation of Functional Human Pancreatic Beta Cells In Vitro
Harvard stem cell researchers have announced that they have made a giant leap forward in the quest to find a truly effective treatment for type 1 diabetes, a condition that affects an estimated 3 million Americans at a cost of about $15 billion annually….
Read More »Exenatide a Noninsulin Addition for Patients Failing Basal Insulin
Exenatide twice daily shows similar glycemic control with weight loss and less hypoglycemia as compared to mealtime insulin… Some patients with advanced type 2 diabetes still do not achieve glycemic control with insulin glargine and metformin. Mealtime insulin lispro is often added on to the regimen but it is associated …
Read More »Fried Food and Risk for Gestational Diabetes
Frequent consumption of fried foods pre-pregnancy increases a woman’s risk for gestational diabetes… Gestational diabetes mellitus is not just a short-term perinatal outcome, but also long-term health complications in both the mothers and baby. The significance of diet and lifestyle is important in the prevention of gestational diabetes mellitus in …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.